Get the Stockscreener App
2.41
0.41%
-0.010
After Hours:
2.42
0.010
+0.41%
Omniab Inc stock is traded at $2.41, with a volume of 607.38K.
It is down -0.41% in the last 24 hours and down -2.82% over the past month.
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
See More
Previous Close:
$2.42
Open:
$2.4
24h Volume:
607.38K
Relative Volume:
0.86
Market Cap:
$349.38M
Revenue:
$28.94M
Net Income/Loss:
$-54.29M
P/E Ratio:
-5.1861
EPS:
-0.4647
Net Cash Flow:
$-26.02M
1W Performance:
-6.23%
1M Performance:
-2.82%
6M Performance:
+30.98%
1Y Performance:
+24.87%
1-Day Range:
$2.32
$2.505
1-Week Range:
$2.32
$2.61
52-Week Range:
$1.30
$2.79
Omniab Inc Stock (OABI) Company Profile
Name
Omniab Inc
Sector
Industry
Phone
510-250-7800
Address
5980 HORTON STREET, EMERYVILLE
Compare OABI vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OABI
Omniab Inc
|
2.41 | 356.63M | 28.94M | -54.29M | -26.02M | -0.4647 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Apr-21-23 | Initiated | The Benchmark Company | Buy |
| Apr-13-23 | Initiated | Craig Hallum | Buy |
| Feb-22-23 | Initiated | Cowen | Outperform |
| Feb-13-23 | Initiated | H.C. Wainwright | Buy |
| Dec-20-22 | Initiated | Truist | Buy |
| Dec-16-22 | Initiated | Credit Suisse | Outperform |
| Nov-29-22 | Initiated | SVB Leerink | Outperform |
| Nov-28-22 | Initiated | Stifel | Buy |
View All
Omniab Inc Stock (OABI) Latest News
OmniAb, Inc. Financial Disclosures & SEC Filings - TradingView
OmniAb, Inc. Warrant 2022- on Omniab Inc Financial Disclosures & SEC Filings - TradingView
OmniAb (NASDAQ:OABI) Cash Burn Looks Manageable - Kalkine Media
Earnings Preview: OmniAb to Report Financial Results Post-market on May 07 - Moomoo
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 2000 Growth Benchmark - marketscreener.com
OmniAb, Inc.(NasdaqGM: OABI) dropped from Russell 3000E Growth Benchmark - marketscreener.com
OmniAb, Inc. Actuals & Estimates (NASDAQ:OABI) - TradingView
OABI Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of OmniAb, Inc. – BOATS:OABIW - TradingView
Price to book forward of OmniAb, Inc. – BOATS:OABIW - TradingView
OmniAb Inc (OABIW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OmniAb Inc (OABIW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OmniAb Inc (OABI) Institutional Confidence - TradingKey
OmniAb shareholders elect directors and ratify auditor at annual meeting By Investing.com - Investing.com Australia
OmniAb shareholders elect directors and ratify auditor at annual meeting - Investing.com UK
OmniAb Shareholders Approve Directors and Auditor at Meeting - TipRanks
OmniAb (OABI) director Bertozzi exercises RSUs and receives new option, RSU grants - Stock Titan
OmniAb (OABI) director adds shares through RSU vesting and new equity grants - Stock Titan
OmniAb (OABI) director receives options and RSUs, exercises 20,000 shares - Stock Titan
OmniAb (OABI) director granted stock options and RSUs - Stock Titan
OmniAb (OABI) director adds options and RSUs in Form 4 filing - Stock Titan
OmniAb (OABI) director gains stock, options and RSUs in Form 4 - Stock Titan
OmniAb (OABI) 2026 annual meeting elects directors and ratifies auditor - Stock Titan
OmniAb Inc (OABIW) Institutional Confidence - TradingKey
OmniAb Inc (OABIW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OmniAb Inc (OABI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Why Is OmniAb Gaining Attention In The Biotechnology Landscape? - Kalkine Media
OmniAb Inc (OABI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OmniAb Inc (OABI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
OmniAb Inc (OABI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OmniAb Inc (OABI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OmniAb Inc (OABIW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OmniAb Inc (OABIW) Valuation: PE, PB & Fair Value Analysis - TradingKey
OmniAb Inc (OABI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OmniAb Inc (OABI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OmniAb Inc (OABI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OmniAb Inc (OABIW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OmniAb Inc (OABIW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OmniAb Inc (OABIW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OABI Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive SentimentAnalyst Consensus Shift - newsline.com
OmniAb, Inc. Hits New 52-Week High of $2.79 Amidst Market Challenges - MarketsMojo
Companies Like OmniAb (NASDAQ:OABI) Are In A Position To Invest In Growth - Yahoo Finance
OABI Stock Price, Quote & Chart | OMNIAB INC (NASDAQ:OABI) - ChartMill
OmniAb Inc. (OABI) Edges Lower as Stock Nears Key Support ZoneFibonacci Retracement - newsline.com
OmniAb (OABI) Hovers Near Key Support After Slight DeclineRunaway Gap - The Legal Advocate
OABI Q1 2026 Earnings: EPS Beat Masks Ongoing R&D InvestmentsUpward Estimate Revision - newsline.com
OABI Q1 2026 Earnings: Wider-than-Expected Loss Narrows as EPS Surprises PositivelyEarnings Yield Spread - newsline.com
OmniAb, Inc. Hits New 52-Week High at USD 2.73 - Markets Mojo
OABIOmniAb Inc Stock Price and Quote - Finviz
OmniAb Stock Is Back Near Its High — Why OABI’s Next Few Days Matter - Bez Kabli
Omniab Inc Stock (OABI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Omniab Inc Stock (OABI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FOEHR MATTHEW W | President and CEO |
Apr 07 '26 |
Option Exercise |
0.00 |
36,459 |
0 |
4,439,736 |
| FOEHR MATTHEW W | President and CEO |
Apr 07 '26 |
Sale |
1.49 |
19,244 |
28,674 |
4,420,492 |
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):